Antisense oligonucleotides containing conformationally constrained 2',4'-(N-methoxy)aminomethylene and 2',4'-aminooxymethylene and 2'-O,4'-C-aminomethylene bridged nucleoside analogues show improved potency in animal models - PubMed (original) (raw)
. 2010 Feb 25;53(4):1636-50.
doi: 10.1021/jm9013295.
Affiliations
- PMID: 20108935
- DOI: 10.1021/jm9013295
Antisense oligonucleotides containing conformationally constrained 2',4'-(N-methoxy)aminomethylene and 2',4'-aminooxymethylene and 2'-O,4'-C-aminomethylene bridged nucleoside analogues show improved potency in animal models
Thazha P Prakash et al. J Med Chem. 2010.
Abstract
To identify chemistries and strategies to improve the potency of MOE second generation ASOs, we have evaluated gapmer antisense oligonucleotides containing BNAs having N-O bonds. These modifications include N-MeO-amino BNA, N-Me-aminooxy BNA, 2',4'-BNA(NC)[NMe], and 2',4'-BNA(NC) bridged nucleoside analogues. These modifications provided increased thermal stability and improved in vitro activity compared to the corresponding ASO containing the MOE modification. Additionally, ASOs containing N-MeO-amino BNA, N-Me-aminooxy BNA, and 2',4'-BNA(NC)[NMe] modifications showed improved in vivo activity (>5-fold) compared to MOE ASO. Importantly, toxicity parameters, such as AST, ALT, liver, kidney, and body weights, were found to be normal for N-MeO-amino BNA, N-Me-aminooxy BNA, and 2',4'-BNA(NC)[NMe] ASO treated animals. The data generated in these experiments suggest that N-MeO-amino BNA, N-Me-aminooxy BNA, and 2',4'-BNA(NC)[NMe] are useful modifications for applications in both antisense and other oligonucleotide based drug discovery efforts.
Similar articles
- Comparing in vitro and in vivo activity of 2'-O-[2-(methylamino)-2-oxoethyl]- and 2'-O-methoxyethyl-modified antisense oligonucleotides.
Prakash TP, Kawasaki AM, Wancewicz EV, Shen L, Monia BP, Ross BS, Bhat B, Manoharan M. Prakash TP, et al. J Med Chem. 2008 May 8;51(9):2766-76. doi: 10.1021/jm701537z. Epub 2008 Apr 10. J Med Chem. 2008. PMID: 18399648 - Short antisense oligonucleotides with novel 2'-4' conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animals.
Seth PP, Siwkowski A, Allerson CR, Vasquez G, Lee S, Prakash TP, Wancewicz EV, Witchell D, Swayze EE. Seth PP, et al. J Med Chem. 2009 Jan 8;52(1):10-3. doi: 10.1021/jm801294h. J Med Chem. 2009. PMID: 19086780 - Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.
Honcharenko D, Barman J, Varghese OP, Chattopadhyaya J. Honcharenko D, et al. Biochemistry. 2007 May 15;46(19):5635-46. doi: 10.1021/bi0620205. Epub 2007 Apr 6. Biochemistry. 2007. PMID: 17411072 - An overview of sugar-modified oligonucleotides for antisense therapeutics.
Prakash TP. Prakash TP. Chem Biodivers. 2011 Sep;8(9):1616-41. doi: 10.1002/cbdv.201100081. Chem Biodivers. 2011. PMID: 21922654 Review. - Synthesis and Characterization of Benzylidene Acetal-Type Bridged Nucleic Acids (BA-BNA).
Kodama T, Morihiro K, Obika S. Kodama T, et al. Curr Protoc Nucleic Acid Chem. 2014 Sep 8;58:1.31.1-22. doi: 10.1002/0471142700.nc0131s58. Curr Protoc Nucleic Acid Chem. 2014. PMID: 25199634 Review.
Cited by
- Superior Silencing by 2',4'-BNA(NC)-Based Short Antisense Oligonucleotides Compared to 2',4'-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors.
Yamamoto T, Yasuhara H, Wada F, Harada-Shiba M, Imanishi T, Obika S. Yamamoto T, et al. J Nucleic Acids. 2012;2012:707323. doi: 10.1155/2012/707323. Epub 2012 Sep 26. J Nucleic Acids. 2012. PMID: 23056920 Free PMC article. - Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice.
Yamamoto T, Harada-Shiba M, Nakatani M, Wada S, Yasuhara H, Narukawa K, Sasaki K, Shibata MA, Torigoe H, Yamaoka T, Imanishi T, Obika S. Yamamoto T, et al. Mol Ther Nucleic Acids. 2012 May 15;1(5):e22. doi: 10.1038/mtna.2012.16. Mol Ther Nucleic Acids. 2012. PMID: 23344002 Free PMC article. - Synthesis and antisense properties of fluoro cyclohexenyl nucleic acid (F-CeNA), a nuclease stable mimic of 2'-fluoro RNA.
Seth PP, Yu J, Jazayeri A, Pallan PS, Allerson CR, Østergaard ME, Liu F, Herdewijn P, Egli M, Swayze EE. Seth PP, et al. J Org Chem. 2012 Jun 1;77(11):5074-85. doi: 10.1021/jo300594b. Epub 2012 May 18. J Org Chem. 2012. PMID: 22591005 Free PMC article. - Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.
Seth PP, Jazayeri A, Yu J, Allerson CR, Bhat B, Swayze EE. Seth PP, et al. Mol Ther Nucleic Acids. 2012 Sep 18;1(10):e47. doi: 10.1038/mtna.2012.34. Mol Ther Nucleic Acids. 2012. PMID: 23344239 Free PMC article. - 5'-O-Methylphosphonate nucleic acids--new modified DNAs that increase the Escherichia coli RNase H cleavage rate of hybrid duplexes.
Šipova H, Špringer T, Rejman D, Šimak O, Petrová M, Novák P, Rosenbergová Š, Páv O, Liboska R, Barvík I, Štěpanek J, Rosenberg I, Homola J. Šipova H, et al. Nucleic Acids Res. 2014 Apr;42(8):5378-89. doi: 10.1093/nar/gku125. Epub 2014 Feb 12. Nucleic Acids Res. 2014. PMID: 24523351 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources